FORMULATION, IN-VITRO RELEASE KINETICS AND STABILITY INTERPRETATION OF SUSTAINED RELEASE TABLETS OF METFORMIN HYDROCHLORIDE
Keywords:
Metformin Hydrochloride, Sustained release, HPMC E15, EC, Release kinetics, StabilityAbstract
Objective: The objective of the present study was to formulate, study the in-vitro release kinetics and stability of sustained release tablets of metformin hydrochloride.
Methods: Sustained release formulations that would maintain the plasma level for 8 – 12 h might be sufficient for daily dosing of metformin. The granules of metformin hydrochloride were prepared by wet granulation method using polymers such as ethyl cellulose (EC) and hydroxyl propyl methyl cellulose E15 (HPMC E15).
Results: The granules were evaluated by determining the angle of repose (26.010±0.110 to 31.950±0.100), bulk density, tapped density, Hausner ratio and Carr's index. It shows satisfactory results. The tablets were subjected to measurement of thickness (4.78 ± 0.07 to 5.20±0.13 mm), weight variation (within limit), drug content (98.08±0.20 to 99.22±0.22%), hardness (9.27±0.16 to10.30±0.97 kg/cm2), friability (0.2to 0.3%w/w), and in-vitro release studies.
Conclusion: It was found that as the concentration of HPMC increased the drug release rate declined due to formation of viscous layer. The release can be fine tuned by adding a hydrophobic polymer like EC in the hydrophilic matrix of HPMC. The release mechanisms were analyzed and were found that the release data was best fitted with Higuchi equation although there is no significant difference between the correlation coefficients of Zero-order and Higuchi model. The result also shows different parameters of stability studies and compare with initial results of different batches.
Â
Downloads
References
Parashar T, Singh VS, Singh G, Tyagi S, Patel C, Gupta A. Novel oral sustained release technology: a concise review. Int J Res Dev Pharm Life Sci 2013;2(2):262-9.
Dunn CJ, Peters DH. Metformin: a review of its pharmacological properties and therapeutic use in non-insulin dependent diabetes mellitus. Drugs 1995;49:721-49.
Defang O, Shufang N, Wei L. In vitro and in vivo evaluation of two extended Release preparations of combination metformin and glipizide. Drug Dev Ind Pharm 2005;31:677-85.
Vinay W, Mohan MV, Manjunath SY. Formulation and evaluation of stomach specific in-situ gel of metoclopramide using natural, bio-degradable polymers. Int J Res Phar Biomed Sci 2011;2(1):193-201.
Ayhan S, Yalçın O, Askın I. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. IL Farmaco 2005;60:171–7.
Elkhodairy AK, Hassan MA, Affi AS. Formulation and optimization of orodispersible tablets of flutamide. Saudi Pharm J 2014;22:53–61.
Das AS, Das S, Samanta A. Formulation and evaluation of controlled release floating capsules of ciprofloxacin HCL. Der Pharm Sin 2013;4(4):72-5.
Ganesh KNG, Sureshkumar R, Jawahar N, Senthil V, Venkatesh DN, Srinivas SM. J Pharm Sci and Res 2010;2(6):360-8.
Basak SC, Rahman J, Ramlingam M. Design and invitro testing of a floatable gast roretenive tablet of metformin hydrochloride. Pharm 2007;62:145-8.
Sakore S, Chakraborty B. Formulation and evaluation of enalapril maleate sustained release matrix. Int J Pharm Biomed Res 2013;4(1):21-6.
Rajesh M, Nagaraju K, Seyed SH, Buhary M. Formulation and evaluation of clarithromycin immediate release film coated tablets. Int J Pharm Pharm Sci 2012;4(Suppl5):352-7.
Mourya DK, Malviya R, Bansal M, Sharma PK. Formulation and release characteristics of novel monolithic hydroxyl propyl methyl cellulose matrix tablets containing metronidazole. Int J Pharm Bio Sci 2010;1(3):1-7.
Giri S, Velmurugan S, Chowdary S. Formulation and evaluation of glipizide sustain release matrix tablets. Int J Pharm Pharm Sci 2013;5(Suppl1):354-60.
Bose A, Wong TW, Singh N. Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics. Saudi Pharm J 2013;21:201-13.